The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125661701 12566170 1 I 2001 20041203 20160718 20160718 EXP GB-GLAXOSMITHKLINE-B0360989A GLAXOSMITHKLINE 0.00 F Y 0.00000 20160718 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125661701 12566170 1 PS PAROXETINE HYDROCHLORIDE. PAROXETINE HYDROCHLORIDE 1 Unknown UNK 20031
125661701 12566170 2 SS Seroxat PAROXETINE HYDROCHLORIDE 1 UNK 20031
125661701 12566170 3 SS Seroxat PAROXETINE HYDROCHLORIDE 1 DOSE REDUCED 20031

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125661701 12566170 1 Depression
125661701 12566170 2 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125661701 12566170 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125661701 12566170 Aggression
125661701 12566170 Agitation
125661701 12566170 Anxiety
125661701 12566170 Arrhythmia
125661701 12566170 Arthralgia
125661701 12566170 Autoimmune thyroiditis
125661701 12566170 Body temperature fluctuation
125661701 12566170 Confusional state
125661701 12566170 Coordination abnormal
125661701 12566170 Cough
125661701 12566170 Crying
125661701 12566170 Depression
125661701 12566170 Diarrhoea
125661701 12566170 Dizziness
125661701 12566170 Drug withdrawal syndrome
125661701 12566170 Dysphagia
125661701 12566170 Dyspnoea
125661701 12566170 Emotional disorder
125661701 12566170 Fatigue
125661701 12566170 Goitre
125661701 12566170 Hyperhidrosis
125661701 12566170 Hyperthyroidism
125661701 12566170 Hypomania
125661701 12566170 Influenza like illness
125661701 12566170 Insomnia
125661701 12566170 Myalgia
125661701 12566170 Nausea
125661701 12566170 Neuropathy peripheral
125661701 12566170 Orthostatic hypotension
125661701 12566170 Pain
125661701 12566170 Pharyngeal oedema
125661701 12566170 Psychomotor hyperactivity
125661701 12566170 Sensory disturbance
125661701 12566170 Sleep disorder
125661701 12566170 Suffocation feeling
125661701 12566170 Suicidal ideation
125661701 12566170 Tinnitus
125661701 12566170 Tremor
125661701 12566170 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125661701 12566170 1 19991008 20010430 0